These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28632869)

  • 1. Phenytoin Toxicity.
    Gupta A; Yek C; Hendler RS
    JAMA; 2017 Jun; 317(23):2445-2446. PubMed ID: 28632869
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenytoin toxicity with mandibular tremor secondary to intravenous administration.
    Türkdogan D; Onat F; Türe U; Pamir N
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):18-9. PubMed ID: 11837377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin-induced encephalopathy in a child.
    Mehndiratta S
    Indian J Pharmacol; 2016; 48(4):460-461. PubMed ID: 27756964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenytoin-induced hypersensitivity reaction with liver failure].
    Colombo-Arnet E
    Praxis (Bern 1994); 2000 Apr; 89(16):675-7. PubMed ID: 10823022
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenytoin as a risk factor in gingival hyperplasia.
    Perlík F; Kolínová M; Zvárová J; Patzelová V
    Ther Drug Monit; 1995 Oct; 17(5):445-8. PubMed ID: 8585105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
    Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
    Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
    [No Abstract]   [Full Text] [Related]  

  • 9. Purple glove syndrome caused by oral administration of phenytoin.
    Yoshikawa H; Abe T; Oda Y
    J Child Neurol; 2000 Nov; 15(11):762. PubMed ID: 11108512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilantin jeopardy: avoiding the dangers of phenytoin.
    Schlicher ML
    Medsurg Nurs; 1998 Dec; 7(6):343-7, 356. PubMed ID: 10036438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing phenytoin intoxication: safer use of a familiar anticonvulsant.
    Glick TH; Workman TP; Gaufberg SV
    J Fam Pract; 2004 Mar; 53(3):197-202. PubMed ID: 15000924
    [No Abstract]   [Full Text] [Related]  

  • 12. Seizures following reduction in phenytoin level after orally administered folic acid.
    Steinweg DL; Bentley ML
    Neurology; 2005 Jun; 64(11):1982. PubMed ID: 15955964
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous phenytoin: rate of administration is critical.
    Alta RN; 2013; 69(1):18-9. PubMed ID: 23713385
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin.
    DeToledo JC; Lowe MR; Rabinstein A; Villaviza N
    Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605
    [No Abstract]   [Full Text] [Related]  

  • 15. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cardiomyopathy in an infant after iatrogenic fosphenytoin overdose.
    Grageda M; Saini AP; Trout LC; Cyran SE; Halstead ES
    Clin Pediatr (Phila); 2014 Jul; 53(8):791-3. PubMed ID: 24146230
    [No Abstract]   [Full Text] [Related]  

  • 17. The medical treatment of epilepsy: maintenance of drug therapy.
    Livingston S; Pruce I; Pauli LL
    Pediatr Ann; 1979 Apr; 8(4):232-54. PubMed ID: 379769
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualization of anticonvulsant therapy.
    Atkinson AJ
    Med Clin North Am; 1974 Sep; 58(5):1037-49. PubMed ID: 4609361
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebral atrophy and skull thickening due to chronic phenytoin therapy.
    Chow KM; Szeto CC
    CMAJ; 2007 Jan; 176(3):321-3. PubMed ID: 17261827
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular motor abnormalities in a patient with phenytoin toxicity--case report and minireview.
    Praveen-kumar S; Desai M
    Clin Neurol Neurosurg; 2014 Dec; 127():116-7. PubMed ID: 25459255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.